Cardiovascular Arrhythmias (including ventricular and supraventricular tachycardia, premature ventricular contractions, and atrial fibrillation), bradycardia, electrocardiographic alterations (including second-degree heart block, QT/QTc interval prolongation, and ST segment depression), palpitations, and syncope
Prior studies have demonstrated superior weight-loss efficacy with higher doses of both agents, but direct comparisons have been limited and often restricted to specific dose combinations or populations without diabetes
Structurally, DSIP is remarkably simple
for some, diarrhea or constipation can be an issue
Another review discussing regenerative and protective actions of GHK-Cu can be found in this PubMed article on GHK-Cu
Alternative Therapies: Transitioning to other weight management medications or strategies if GLP-1s are no longer suitable